{"schemaVersion":"peptidescanner-peptide-evidence-feed/v1","canonicalUrl":"https://peptidescanner.com/feeds/peptides/lanreotide.json","peptide":{"slug":"lanreotide","name":"Lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"},"release":{"label":"Beta · 15 Sep 2026","reviewedAt":"2026-09-15"},"entryCount":70,"entries":[{"objectId":"story:clinicaltrials-gov-nct02493517-lanreotide:v1","state":"current","stateChangedAt":"2026-09-09","title":"ClinicalTrials.gov record NCT02493517","domain":"Clinical trials","dateInSource":"2019-01-29","publishedAt":"2026-09-09","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02493517-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct02493517-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct02493517-lanreotide-v1.md","contentSha256":"87380367948f09c398d810a8079dbb6c24a845950eb4f757ea1208e87164fe91"},{"objectId":"story:pubmed-pmid-8813476-lanreotide:v1","state":"current","stateChangedAt":"2026-09-09","title":"The use of new somatostatin analogues, lanreotide and octastatin, in neuroendocrine gastro-intestinal tumours.","domain":"Literature metadata","dateInSource":"2018-02-16","publishedAt":"2026-09-09","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-8813476-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-8813476-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-8813476-lanreotide-v1.md","contentSha256":"0ce4a1b8151951dfcae0d9bed8004b4054e88605274bdc363d63e1406dbcf699"},{"objectId":"story:fda-enforcement-d-0290-2026:v1","state":"current","stateChangedAt":"2026-08-25","title":"FDA enforcement report D-0290-2026","domain":"Safety","dateInSource":"2026-01-21","publishedAt":"2026-08-25","humanUrl":"https://peptidescanner.com/stories/fda-enforcement-d-0290-2026/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/fda-enforcement-d-0290-2026-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/fda-enforcement-d-0290-2026-v1.md","contentSha256":"fe293b34076235ed4181b7faf420533638e4a0d97eb4b2337734052dd97f2c29"},{"objectId":"story:fda-enforcement-d-0422-2026:v1","state":"current","stateChangedAt":"2026-08-25","title":"FDA enforcement report D-0422-2026","domain":"Safety","dateInSource":"2026-04-15","publishedAt":"2026-08-25","humanUrl":"https://peptidescanner.com/stories/fda-enforcement-d-0422-2026/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/fda-enforcement-d-0422-2026-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/fda-enforcement-d-0422-2026-v1.md","contentSha256":"352b28669a0abac4d37203e67ea06db4237716a8361e4b5f97094118947cfd19"},{"objectId":"story:fda-enforcement-d-0423-2026:v1","state":"current","stateChangedAt":"2026-08-25","title":"FDA enforcement report D-0423-2026","domain":"Safety","dateInSource":"2026-04-15","publishedAt":"2026-08-25","humanUrl":"https://peptidescanner.com/stories/fda-enforcement-d-0423-2026/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/fda-enforcement-d-0423-2026-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/fda-enforcement-d-0423-2026-v1.md","contentSha256":"9236285728ef4f121af6edc89f0e61aedd709e83a9034eb1b2e0c08f1a5ddfa5"},{"objectId":"story:dailymed-label-lanreotide-2892b4c3-0329-4d29-97ff-3b45283bbab1-v1:v1","state":"current","stateChangedAt":"2026-08-22","title":"Lanreotide DailyMed SPL version 1","domain":"Regulatory","dateInSource":"2024-05-23","publishedAt":"2026-08-22","humanUrl":"https://peptidescanner.com/stories/dailymed-label-lanreotide-2892b4c3-0329-4d29-97ff-3b45283bbab1-v1/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/dailymed-label-lanreotide-2892b4c3-0329-4d29-97ff-3b45283bbab1-v1-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/dailymed-label-lanreotide-2892b4c3-0329-4d29-97ff-3b45283bbab1-v1-v1.md","contentSha256":"c9f0e582dcd0197ce316d8e67597df3ad2d23285fd3fb1a15c158d8d7e721694"},{"objectId":"story:dailymed-label-lanreotide-2892b4c3-0329-4d29-97ff-3b45283bbab1-v2:v1","state":"current","stateChangedAt":"2026-08-22","title":"Lanreotide DailyMed SPL version 2","domain":"Regulatory","dateInSource":"2024-12-02","publishedAt":"2026-08-22","humanUrl":"https://peptidescanner.com/stories/dailymed-label-lanreotide-2892b4c3-0329-4d29-97ff-3b45283bbab1-v2/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/dailymed-label-lanreotide-2892b4c3-0329-4d29-97ff-3b45283bbab1-v2-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/dailymed-label-lanreotide-2892b4c3-0329-4d29-97ff-3b45283bbab1-v2-v1.md","contentSha256":"dc52b973605e4b06fd1b5b1434d2bb5a17bfe633ee797bd7d580708426eda91d"},{"objectId":"story:dailymed-label-lanreotide-2892b4c3-0329-4d29-97ff-3b45283bbab1-v3:v1","state":"current","stateChangedAt":"2026-08-22","title":"Lanreotide DailyMed SPL version 3","domain":"Regulatory","dateInSource":"2025-06-02","publishedAt":"2026-08-22","humanUrl":"https://peptidescanner.com/stories/dailymed-label-lanreotide-2892b4c3-0329-4d29-97ff-3b45283bbab1-v3/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/dailymed-label-lanreotide-2892b4c3-0329-4d29-97ff-3b45283bbab1-v3-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/dailymed-label-lanreotide-2892b4c3-0329-4d29-97ff-3b45283bbab1-v3-v1.md","contentSha256":"ec3b0da98d3a5ae88e00e94d31d09139d91aafba8b95bb177bc235c9992e4175"},{"objectId":"story:federal-register-2014-17293:v1","state":"current","stateChangedAt":"2026-08-21","title":"Federal Register notice 2014-17293","domain":"Regulatory","dateInSource":"2014-07-23","publishedAt":"2026-08-21","humanUrl":"https://peptidescanner.com/stories/federal-register-2014-17293/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/federal-register-2014-17293-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/federal-register-2014-17293-v1.md","contentSha256":"07acde9eb28b3849b81b0a4bc5df95afd5374184bde5827e7659cd37d7f71955"},{"objectId":"story:federal-register-e8-27179:v1","state":"current","stateChangedAt":"2026-08-21","title":"Federal Register notice E8-27179","domain":"Regulatory","dateInSource":"2008-11-17","publishedAt":"2026-08-21","humanUrl":"https://peptidescanner.com/stories/federal-register-e8-27179/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/federal-register-e8-27179-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/federal-register-e8-27179-v1.md","contentSha256":"dcc4035c2aba9044b9b1869c6e9ff88496cf52df77a80e5d73718b31a7b8e107"},{"objectId":"story:clinicaltrials-gov-nct00774930-lanreotide:v1","state":"current","stateChangedAt":"2026-08-14","title":"ClinicalTrials.gov record NCT00774930","domain":"Clinical trials","dateInSource":"2022-10-14","publishedAt":"2026-08-14","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00774930-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00774930-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00774930-lanreotide-v1.md","contentSha256":"9b9ec001c1d6f207d3b626ca143c9b559707a62b49e7f38f8b2a8875b3e1be62"},{"objectId":"story:fda-drugs-anda217193:v1","state":"current","stateChangedAt":"2026-08-14","title":"Drugs@FDA application ANDA217193","domain":"Regulatory","dateInSource":"2024-05-21","publishedAt":"2026-08-14","humanUrl":"https://peptidescanner.com/stories/fda-drugs-anda217193/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/fda-drugs-anda217193-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/fda-drugs-anda217193-v1.md","contentSha256":"42dc593a71eaa703af29dcf820232d65ffcbc1e614d3dd82cd4df76694dc6d51"},{"objectId":"story:fda-drugs-nda022074:v1","state":"current","stateChangedAt":"2026-08-14","title":"Drugs@FDA application NDA022074","domain":"Regulatory","dateInSource":"2007-08-30","publishedAt":"2026-08-14","humanUrl":"https://peptidescanner.com/stories/fda-drugs-nda022074/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/fda-drugs-nda022074-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/fda-drugs-nda022074-v1.md","contentSha256":"2694e8c4a581c294efb90c5cc60699a456f7d6f619190ed824407affc6e051b0"},{"objectId":"story:fda-drugs-nda215395:v1","state":"current","stateChangedAt":"2026-08-14","title":"Drugs@FDA application NDA215395","domain":"Regulatory","dateInSource":"2021-12-17","publishedAt":"2026-08-14","humanUrl":"https://peptidescanner.com/stories/fda-drugs-nda215395/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/fda-drugs-nda215395-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/fda-drugs-nda215395-v1.md","contentSha256":"bfbf6b5399897fddcddc3b2804e95ad98422b661a643209bcc6a3479a98569eb"},{"objectId":"story:pubmed-pmid-15789272-lanreotide:v1","state":"current","stateChangedAt":"2026-08-14","title":"Four-year follow-up of acromegalic patients treated with the new long-acting formulation of Lanreotide (Lanreotide Autogel).","domain":"Literature metadata","dateInSource":"2026-01-28","publishedAt":"2026-08-14","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-15789272-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-15789272-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-15789272-lanreotide-v1.md","contentSha256":"b4c197e60c69ce49036fc29499b052a1bfcb451ebbd52bc56d2b4c59b34af771"},{"objectId":"story:pubmed-pmid-25746137-lanreotide:v1","state":"current","stateChangedAt":"2026-08-14","title":"Combinative treatment of transarterial chemoembolization, celecoxib and lanreotide in unresectable hepatocellular carcinoma.","domain":"Literature metadata","dateInSource":"2016-11-25","publishedAt":"2026-08-14","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-25746137-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-25746137-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-25746137-lanreotide-v1.md","contentSha256":"3286ada9125d73922c22f2045a2ee86edbd27d386fa9bc122728457a3018d28a"},{"objectId":"story:pubmed-pmid-8099735-lanreotide:v1","state":"current","stateChangedAt":"2026-08-14","title":"[Treatment of acromegaly with sustained-release lanreotide. A new somatostatin analog].","domain":"Literature metadata","dateInSource":"2016-12-09","publishedAt":"2026-08-14","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-8099735-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-8099735-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-8099735-lanreotide-v1.md","contentSha256":"521d929eaf5487623ac33123a25ec478b9849f3275ce034ebca203bd9f615aef"},{"objectId":"story:pubmed-pmid-12037499-lanreotide:v1","state":"current","stateChangedAt":"2026-08-13","title":"[Somatuline(R) Autogel(R), a new formulation of lanreotide for the treatment of acromegalic patients].","domain":"Literature metadata","dateInSource":"2016-11-24","publishedAt":"2026-08-13","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-12037499-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-12037499-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-12037499-lanreotide-v1.md","contentSha256":"58bb115edd186d161c21763be91a0e4863a23b1614189bc2efcc8ad40705c6ab"},{"objectId":"story:pubmed-pmid-15789913-lanreotide:v1","state":"current","stateChangedAt":"2026-08-13","title":"[Lanreotide in the treatment of thyroid orbitopathy].","domain":"Literature metadata","dateInSource":"2016-11-24","publishedAt":"2026-08-13","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-15789913-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-15789913-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-15789913-lanreotide-v1.md","contentSha256":"09867800a17d786c986ac1625a9f58ef71425ab26e81ba097d2447ec6d9a8a50"},{"objectId":"story:pubmed-pmid-16154424-lanreotide:v1","state":"current","stateChangedAt":"2026-08-13","title":"Pharmacokinetics and population pharmacodynamic analysis of lanreotide Autogel.","domain":"Literature metadata","dateInSource":"2016-11-24","publishedAt":"2026-08-13","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-16154424-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-16154424-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-16154424-lanreotide-v1.md","contentSha256":"4694922e754432d3b61fec29646cbe3d0fdd1782d3e74483c4295360bdfeaf57"},{"objectId":"story:pubmed-pmid-17854356-lanreotide:v1","state":"current","stateChangedAt":"2026-08-13","title":"Radiation recall dermatitis in a patient affected with pheochromocytoma after treatment with lanreotide.","domain":"Literature metadata","dateInSource":"2016-11-24","publishedAt":"2026-08-13","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-17854356-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-17854356-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-17854356-lanreotide-v1.md","contentSha256":"92b81965122e61c6bbd378f76b6d27889cac2b7436f1127a6ec0f4339583b366"},{"objectId":"story:pubmed-pmid-17929329-lanreotide:v1","state":"current","stateChangedAt":"2026-08-13","title":"Self-assembly of the octapeptide lanreotide and lanreotide-based derivatives: the role of the aromatic residues.","domain":"Literature metadata","dateInSource":"2016-11-24","publishedAt":"2026-08-13","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-17929329-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-17929329-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-17929329-lanreotide-v1.md","contentSha256":"9cc8a749c3e1cc40f5f54e9db46e8d5b595a80330521cc35b99fe16854df70db"},{"objectId":"story:pubmed-pmid-17984236-lanreotide:v1","state":"current","stateChangedAt":"2026-08-13","title":"Optimalization and cost management of lanreotide-Autogel therapy in acromegaly.","domain":"Literature metadata","dateInSource":"2016-11-24","publishedAt":"2026-08-13","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-17984236-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-17984236-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-17984236-lanreotide-v1.md","contentSha256":"3a48c263b5ec4d5dba7f9f7c4932317cfc6080d1c9e9e435c3bf344937394e8f"},{"objectId":"story:pubmed-pmid-18063933-lanreotide:v1","state":"current","stateChangedAt":"2026-08-13","title":"Lanreotide autogel and insulin sensitivity markers: report of 5 acromegalic patients and literature review.","domain":"Literature metadata","dateInSource":"2016-11-24","publishedAt":"2026-08-13","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-18063933-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-18063933-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-18063933-lanreotide-v1.md","contentSha256":"aedc4d72dc9624feb50f4829bf0a8c0019b3cb2e6c50c525226d7215089976e2"},{"objectId":"story:pubmed-pmid-18367285-lanreotide:v1","state":"current","stateChangedAt":"2026-08-13","title":"Lanreotide Autogel for persistent diabetic macular edema.","domain":"Literature metadata","dateInSource":"2016-11-24","publishedAt":"2026-08-13","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-18367285-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-18367285-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-18367285-lanreotide-v1.md","contentSha256":"7b39584fe1306173b2dc78af59203d221b53a7ea4165903321b1d3c2c4681027"},{"objectId":"story:pubmed-pmid-18684551-lanreotide:v1","state":"current","stateChangedAt":"2026-08-13","title":"Para-aortic lymphocele treated with an injection of somatostatine analog (lanreotide).","domain":"Literature metadata","dateInSource":"2016-11-24","publishedAt":"2026-08-13","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-18684551-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-18684551-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-18684551-lanreotide-v1.md","contentSha256":"a4942b3c06a35fd6edbe7cb1c59b7235e2be39aab94e701a2c1a13ed4243704b"},{"objectId":"story:pubmed-pmid-19258715-lanreotide:v1","state":"current","stateChangedAt":"2026-08-13","title":"Long-acting lanreotide in adolescent girls with constitutional tall stature.","domain":"Literature metadata","dateInSource":"2016-11-25","publishedAt":"2026-08-13","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-19258715-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-19258715-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-19258715-lanreotide-v1.md","contentSha256":"f02b3579a133b2f34b235f53d4a5831d11ef2e4fef279fc59384702cf6eb7ebf"},{"objectId":"story:pubmed-pmid-20168286-lanreotide:v1","state":"current","stateChangedAt":"2026-08-13","title":"Preliminary experience with (68)Ga-DOTA-lanreotide positron emission tomography.","domain":"Literature metadata","dateInSource":"2016-11-25","publishedAt":"2026-08-13","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-20168286-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-20168286-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-20168286-lanreotide-v1.md","contentSha256":"3aab52d668f9ec05bda8924d548f1e1778da7a43056768d4b95b339fec6c7880"},{"objectId":"story:pubmed-pmid-20199027-lanreotide:v1","state":"current","stateChangedAt":"2026-08-13","title":"Elucidation of the self-assembly pathway of lanreotide octapeptide into beta-sheet nanotubes: role of two stable intermediates.","domain":"Literature metadata","dateInSource":"2016-11-25","publishedAt":"2026-08-13","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-20199027-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-20199027-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-20199027-lanreotide-v1.md","contentSha256":"7ef1e9deb988d6bd822cccdbcf84701bccf5e80fb872642d6cf6ea1dc2087919"},{"objectId":"story:pubmed-pmid-20604834-lanreotide:v1","state":"current","stateChangedAt":"2026-08-13","title":"Therapeutic 188Re-lanreotide: determination of radiopharmacokinetic parameters in rats.","domain":"Literature metadata","dateInSource":"2016-11-25","publishedAt":"2026-08-13","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-20604834-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-20604834-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-20604834-lanreotide-v1.md","contentSha256":"98f3f7989c5d2988ac8f6ca54d4bcbf8199f9c1742e3132ca7ac44b7cc323767"},{"objectId":"story:pubmed-pmid-21135689-lanreotide:v1","state":"current","stateChangedAt":"2026-08-13","title":"Use of lanreotide for the treatment of gastrointestinal fistulae.","domain":"Literature metadata","dateInSource":"2016-11-25","publishedAt":"2026-08-13","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-21135689-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-21135689-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-21135689-lanreotide-v1.md","contentSha256":"2d1d38e8af848f896e8d1d19a1e6c7f834ac75b2c00e2d6681f0b2869493209c"},{"objectId":"story:pubmed-pmid-25682623-lanreotide:v1","state":"current","stateChangedAt":"2026-08-13","title":"Resolving bile reflux by lanreotide in patients with Roux-en-Y gastrojejunostomy.","domain":"Literature metadata","dateInSource":"2016-11-25","publishedAt":"2026-08-13","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-25682623-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-25682623-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-25682623-lanreotide-v1.md","contentSha256":"6f3c931c79d3edf1d3adbe9534eab4b898a58030bcb0eda812292038e1200039"},{"objectId":"story:pubmed-pmid-38206830-lanreotide:v1","state":"current","stateChangedAt":"2026-08-13","title":"Combined Lanreotide Autogel and Temozolomide Treatment of Progressive Pancreatic and Intestinal Neuroendocrine Tumors: The Phase II SONNET Study.","domain":"Literature metadata","dateInSource":"2026-04-30","publishedAt":"2026-08-13","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-38206830-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-38206830-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-38206830-lanreotide-v1.md","contentSha256":"e8a103f42e326c42fee06a2b802d7a3918b9431ca18eef55e74bdfe9897daf0c"},{"objectId":"story:pubmed-pmid-39491674-lanreotide:v1","state":"current","stateChangedAt":"2026-08-13","title":"β-Cyclodextrin derivatives bind aromatic side chains of the cyclic peptide lanreotide.","domain":"Literature metadata","dateInSource":"2026-05-17","publishedAt":"2026-08-13","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-39491674-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-39491674-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-39491674-lanreotide-v1.md","contentSha256":"12f0204fcfa2e80214652e6166ea8a2b29dd955fdcd55de083a3877af33d2d74"},{"objectId":"story:pubmed-pmid-41071230-lanreotide:v1","state":"current","stateChangedAt":"2026-08-13","title":"Lanreotide in endothelial corneal inflammation.","domain":"Literature metadata","dateInSource":"2026-03-25","publishedAt":"2026-08-13","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-41071230-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-41071230-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-41071230-lanreotide-v1.md","contentSha256":"88dddbfa40c80f3a543a974032a5ffea80b414e67cdea03507474d691347d69f"},{"objectId":"story:pubmed-pmid-10199803-lanreotide:v1","state":"current","stateChangedAt":"2026-08-12","title":"PubMed record PMID 10199803","domain":"Literature metadata","dateInSource":"2016-11-24","publishedAt":"2026-08-12","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-10199803-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-10199803-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-10199803-lanreotide-v1.md","contentSha256":"0544e726d516341cda77fc2a074d9b7e3fd304798df4f15301abfc5c45c70ab0"},{"objectId":"story:pubmed-pmid-10231313-lanreotide:v1","state":"current","stateChangedAt":"2026-08-12","title":"PubMed record PMID 10231313","domain":"Literature metadata","dateInSource":"2016-11-24","publishedAt":"2026-08-12","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-10231313-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-10231313-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-10231313-lanreotide-v1.md","contentSha256":"10a9b42a13d2c3c55498f8e28b6ddbea839f3c82e6ec57c38dd59716d08e9e82"},{"objectId":"story:pubmed-pmid-10480146-lanreotide:v1","state":"current","stateChangedAt":"2026-08-12","title":"PubMed record PMID 10480146","domain":"Literature metadata","dateInSource":"2016-11-24","publishedAt":"2026-08-12","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-10480146-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-10480146-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-10480146-lanreotide-v1.md","contentSha256":"900e9a8cca210decd760df458db075322a53a2f80bf07f79440033e39c8250b1"},{"objectId":"story:pubmed-pmid-10579475-lanreotide:v1","state":"current","stateChangedAt":"2026-08-12","title":"PubMed record PMID 10579475","domain":"Literature metadata","dateInSource":"2016-11-24","publishedAt":"2026-08-12","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-10579475-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-10579475-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-10579475-lanreotide-v1.md","contentSha256":"f7d7108ee80e52112fec27b556fe3998e352519f9eb60776c624792bab537709"},{"objectId":"story:pubmed-pmid-10748802-lanreotide:v1","state":"current","stateChangedAt":"2026-08-12","title":"PubMed record PMID 10748802","domain":"Literature metadata","dateInSource":"2016-11-24","publishedAt":"2026-08-12","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-10748802-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-10748802-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-10748802-lanreotide-v1.md","contentSha256":"05a068981acbefb9f8a396474212dc16c274c6fcfdbd10fa8170db8863f6ae32"},{"objectId":"story:pubmed-pmid-11095353-lanreotide:v1","state":"current","stateChangedAt":"2026-08-12","title":"PubMed record PMID 11095353","domain":"Literature metadata","dateInSource":"2016-11-24","publishedAt":"2026-08-12","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-11095353-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-11095353-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-11095353-lanreotide-v1.md","contentSha256":"64e3550bea26d4017388b0d9f82d26a2c71bfe23f9e25cdb0e3102adce4a9db5"},{"objectId":"story:pubmed-pmid-11128563-lanreotide:v1","state":"current","stateChangedAt":"2026-08-12","title":"PubMed record PMID 11128563","domain":"Literature metadata","dateInSource":"2016-11-24","publishedAt":"2026-08-12","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-11128563-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-11128563-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-11128563-lanreotide-v1.md","contentSha256":"f0800d09685a9a87f3c29d0399cd643eaf26e0a83cd245bcdb7cc5a8765c0f6b"},{"objectId":"story:pubmed-pmid-38071418-lanreotide:v1","state":"current","stateChangedAt":"2026-08-12","title":"PubMed record PMID 38071418","domain":"Literature metadata","dateInSource":"2026-05-18","publishedAt":"2026-08-12","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-38071418-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-38071418-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-38071418-lanreotide-v1.md","contentSha256":"c54916c56343f0b7547835c4de154a31a1bb04902ae95578ae56c842c36cb870"},{"objectId":"story:pubmed-pmid-39933708-lanreotide:v1","state":"current","stateChangedAt":"2026-08-12","title":"PubMed record PMID 39933708","domain":"Literature metadata","dateInSource":"2026-06-09","publishedAt":"2026-08-12","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-39933708-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-39933708-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-39933708-lanreotide-v1.md","contentSha256":"43b7d731f4242a0ab4e5c1813cce00ee1135f88f58aa55898a2323f7d727145d"},{"objectId":"story:pubmed-pmid-41880072-lanreotide:v1","state":"current","stateChangedAt":"2026-08-12","title":"PubMed record PMID 41880072","domain":"Literature metadata","dateInSource":"2026-06-27","publishedAt":"2026-08-12","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-41880072-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-41880072-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-41880072-lanreotide-v1.md","contentSha256":"d489f415f025e7e12ae5f3e782ebebaafca4f5a3e9a80aeee3be3fe9f34da68c"},{"objectId":"story:pubmed-pmid-8954072-lanreotide:v1","state":"current","stateChangedAt":"2026-08-12","title":"PubMed record PMID 8954072","domain":"Literature metadata","dateInSource":"2016-11-24","publishedAt":"2026-08-12","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-8954072-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-8954072-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-8954072-lanreotide-v1.md","contentSha256":"2809a3330c989b15484b561fc1ea07fd8f021d94f841cc3015db9fc5c360aa3e"},{"objectId":"story:pubmed-pmid-8975096-lanreotide:v1","state":"current","stateChangedAt":"2026-08-12","title":"PubMed record PMID 8975096","domain":"Literature metadata","dateInSource":"2016-11-23","publishedAt":"2026-08-12","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-8975096-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-8975096-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-8975096-lanreotide-v1.md","contentSha256":"c852c8fcb56a3fd913d2be7f084997cf7bda7497e2bd440986e678c53b7e0645"},{"objectId":"story:pubmed-pmid-9119171-lanreotide:v1","state":"current","stateChangedAt":"2026-08-12","title":"PubMed record PMID 9119171","domain":"Literature metadata","dateInSource":"2016-11-24","publishedAt":"2026-08-12","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-9119171-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-9119171-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-9119171-lanreotide-v1.md","contentSha256":"e503abc77b5f0403b3259a932e9562c6a7aaebe04961c64ec9a43a8a63145acf"},{"objectId":"story:pubmed-pmid-9537429-lanreotide:v1","state":"current","stateChangedAt":"2026-08-12","title":"PubMed record PMID 9537429","domain":"Literature metadata","dateInSource":"2016-11-24","publishedAt":"2026-08-12","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-9537429-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-9537429-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-9537429-lanreotide-v1.md","contentSha256":"a0342a44e1f06b24e5c49717c16de920aaf0d90f74acff1df6540b3d2f2a6988"},{"objectId":"story:pubmed-pmid-9867148-lanreotide:v1","state":"current","stateChangedAt":"2026-08-12","title":"PubMed record PMID 9867148","domain":"Literature metadata","dateInSource":"2016-11-24","publishedAt":"2026-08-12","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-9867148-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-9867148-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-9867148-lanreotide-v1.md","contentSha256":"ab49ea8ddfe3eb93567d74e17b869cee717ee34f06b5b19562ea2616d87bdb7d"},{"objectId":"story:pubmed-pmid-9934776-lanreotide:v1","state":"current","stateChangedAt":"2026-08-12","title":"PubMed record PMID 9934776","domain":"Literature metadata","dateInSource":"2016-11-24","publishedAt":"2026-08-12","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-9934776-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-9934776-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-9934776-lanreotide-v1.md","contentSha256":"9214bcf5b90e6a0347a067e44323139e58f09a050f8806787c14e08135e81398"},{"objectId":"story:pubmed-pmid-7864583-lanreotide:v1","state":"current","stateChangedAt":"2026-08-11","title":"PubMed record PMID 7864583","domain":"Literature metadata","dateInSource":"2016-11-23","publishedAt":"2026-08-11","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-7864583-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-7864583-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-7864583-lanreotide-v1.md","contentSha256":"520eca4fab412c8d3235a0035f0b951d3fcc64265198c310d1840586db156667"},{"objectId":"story:pubmed-pmid-8646723-lanreotide:v1","state":"current","stateChangedAt":"2026-08-11","title":"PubMed record PMID 8646723","domain":"Literature metadata","dateInSource":"2016-11-23","publishedAt":"2026-08-11","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-8646723-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-8646723-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-8646723-lanreotide-v1.md","contentSha256":"9f0adb7515b03b96afdc32b3f79520ce0c497b492ef61c94f2c439dcfdb75c10"},{"objectId":"story:pubmed-pmid-8786564-lanreotide:v1","state":"current","stateChangedAt":"2026-08-11","title":"PubMed record PMID 8786564","domain":"Literature metadata","dateInSource":"2016-11-23","publishedAt":"2026-08-11","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-8786564-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-8786564-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-8786564-lanreotide-v1.md","contentSha256":"520c89f240367ba6077616c861a14f555381cf1a752cd1305f3f3f9bb74f3fea"},{"objectId":"story:pubmed-pmid-8931985-lanreotide:v1","state":"current","stateChangedAt":"2026-08-11","title":"PubMed record PMID 8931985","domain":"Literature metadata","dateInSource":"2016-11-23","publishedAt":"2026-08-11","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-8931985-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-8931985-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-8931985-lanreotide-v1.md","contentSha256":"e2801518e04fafb01f776121c3f31233890ef7488c7c3b32d31951faeebfe18c"},{"objectId":"story:pubmed-pmid-15003204-lanreotide:v1","state":"current","stateChangedAt":"2026-08-10","title":"PubMed record PMID 15003204","domain":"Literature metadata","dateInSource":"2014-08-18","publishedAt":"2026-08-10","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-15003204-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-15003204-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-15003204-lanreotide-v1.md","contentSha256":"e3d4d663c7344a2d935c4823fbfe8bbc1e49c35b417259918eb823645abeded1"},{"objectId":"story:pubmed-pmid-21607321-lanreotide:v1","state":"current","stateChangedAt":"2026-08-10","title":"PubMed record PMID 21607321","domain":"Literature metadata","dateInSource":"2011-05-24","publishedAt":"2026-08-10","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-21607321-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-21607321-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-21607321-lanreotide-v1.md","contentSha256":"f85941a2810fb2e5ffa38036b73777526197fb86fbfe8ce7989abf00f00e37bc"},{"objectId":"story:pubmed-pmid-27200668-lanreotide:v1","state":"current","stateChangedAt":"2026-08-10","title":"PubMed record PMID 27200668","domain":"Literature metadata","dateInSource":"2016-05-21","publishedAt":"2026-08-10","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-27200668-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-27200668-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-27200668-lanreotide-v1.md","contentSha256":"4339c7650dd4cd827d55eba9d190b103599dca46e162b037d83553711978cff5"},{"objectId":"story:pubmed-pmid-7540120-lanreotide:v1","state":"current","stateChangedAt":"2026-08-10","title":"PubMed record PMID 7540120","domain":"Literature metadata","dateInSource":"2016-11-23","publishedAt":"2026-08-10","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-7540120-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-7540120-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-7540120-lanreotide-v1.md","contentSha256":"b1de16586eca0e21bf27b6219c064c0fb994c7fb0e411c68c1d837a1afb68740"},{"objectId":"story:clinicaltrials-gov-nct00565097-lanreotide:v1","state":"current","stateChangedAt":"2026-08-09","title":"ClinicalTrials.gov record NCT00565097","domain":"Clinical trials","dateInSource":"2009-02-17","publishedAt":"2026-08-09","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00565097-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00565097-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00565097-lanreotide-v1.md","contentSha256":"c57189a6ce23823af5f3f1df04a24795aaab74869271a79bfe6023e9e12ea0d6"},{"objectId":"story:clinicaltrials-gov-nct01354405-lanreotide:v1","state":"current","stateChangedAt":"2026-08-09","title":"ClinicalTrials.gov record NCT01354405","domain":"Clinical trials","dateInSource":"2014-07-09","publishedAt":"2026-08-09","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01354405-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01354405-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01354405-lanreotide-v1.md","contentSha256":"1ab58e4a2538a03979f906c7649ff867c6f697d58b36991b042c5f8e783ea09d"},{"objectId":"story:clinicaltrials-gov-nct02075606-lanreotide:v1","state":"current","stateChangedAt":"2026-08-09","title":"ClinicalTrials.gov record NCT02075606","domain":"Clinical trials","dateInSource":"2019-06-07","publishedAt":"2026-08-09","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02075606-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct02075606-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct02075606-lanreotide-v1.md","contentSha256":"cfbd757bf1acdd593d90683bd12c2bf4d42ea1038ebb4e311962703c38846a94"},{"objectId":"story:clinicaltrials-gov-nct02351128-lanreotide:v1","state":"current","stateChangedAt":"2026-08-09","title":"ClinicalTrials.gov record NCT02351128","domain":"Clinical trials","dateInSource":"2017-10-18","publishedAt":"2026-08-09","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02351128-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct02351128-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct02351128-lanreotide-v1.md","contentSha256":"36fbecf1902eae3f41ac941f748b58fb3d6f951b65bfdda4dc9ca493fb01ee48"},{"objectId":"story:clinicaltrials-gov-nct03012594-lanreotide:v1","state":"current","stateChangedAt":"2026-08-09","title":"ClinicalTrials.gov record NCT03012594","domain":"Clinical trials","dateInSource":"2021-01-15","publishedAt":"2026-08-09","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03012594-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct03012594-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct03012594-lanreotide-v1.md","contentSha256":"3becbc3b33425028a30309bd4afef33ffc19abee7f22d722a63e6f8d78350030"},{"objectId":"story:clinicaltrials-gov-nct03043664-lanreotide:v1","state":"current","stateChangedAt":"2026-08-09","title":"ClinicalTrials.gov record NCT03043664","domain":"Clinical trials","dateInSource":"2023-06-29","publishedAt":"2026-08-09","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03043664-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct03043664-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct03043664-lanreotide-v1.md","contentSha256":"d1bfa6627f5f24b652d16229b61d07a637df772372c37beab8219bbfd8c03670"},{"objectId":"story:clinicaltrials-gov-nct03158090-lanreotide:v1","state":"current","stateChangedAt":"2026-08-09","title":"ClinicalTrials.gov record NCT03158090","domain":"Clinical trials","dateInSource":"2022-03-16","publishedAt":"2026-08-09","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03158090-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct03158090-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct03158090-lanreotide-v1.md","contentSha256":"b01fac56dfb7e987b316cf8be23545faf0a7dc8b247f9bfc48efcdb3ba587d9d"},{"objectId":"story:clinicaltrials-gov-nct03946527-lanreotide:v1","state":"current","stateChangedAt":"2026-08-09","title":"ClinicalTrials.gov record NCT03946527","domain":"Clinical trials","dateInSource":"2026-03-02","publishedAt":"2026-08-09","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03946527-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct03946527-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct03946527-lanreotide-v1.md","contentSha256":"e01334e25fed34ab21d5ce17c2016b2dbdadeb19d0d859cc5e450fb2ad5b8f29"},{"objectId":"story:clinicaltrials-gov-nct06807437-lanreotide:v1","state":"current","stateChangedAt":"2026-08-09","title":"ClinicalTrials.gov record NCT06807437","domain":"Clinical trials","dateInSource":"2026-03-31","publishedAt":"2026-08-09","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct06807437-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct06807437-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct06807437-lanreotide-v1.md","contentSha256":"ec4e11f6654fa99491f1cc5b19dcc69d57667ae331adda86eb9ad502482fe912"},{"objectId":"story:clinicaltrials-gov-nct02127437-lanreotide:v1","state":"current","stateChangedAt":"2026-08-08","title":"ClinicalTrials.gov record NCT02127437","domain":"Clinical trials","dateInSource":"2026-04-08","publishedAt":"2026-08-08","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02127437-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct02127437-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct02127437-lanreotide-v1.md","contentSha256":"524ab5dd26896eeb8cadf3e0801beb94d9bfd8a4c4c71d159cd8e2ebddd09b3f"},{"objectId":"story:clinicaltrials-gov-nct05048901-lanreotide:v1","state":"current","stateChangedAt":"2026-08-08","title":"ClinicalTrials.gov record NCT05048901","domain":"Clinical trials","dateInSource":"2026-04-09","publishedAt":"2026-08-08","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct05048901-lanreotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct05048901-lanreotide-v1.json","markdownUrl":"https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct05048901-lanreotide-v1.md","contentSha256":"284198ac719ebbc50f3d51e693fb301aa6194359bfc2ab3e0d8dd808ac23c497"}]}